Netvax
Withdrawn
This medicine's authorisation has been withdrawn
adjuvanted vaccine against necrotic enteritis of chickens due to Clostridium perfringens
MedicineVeterinaryWithdrawn
Swedish is available via eTranslation, the European Commission's machine translation service.
Translate to Swedish | Important information about machine translation
- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
The marketing authorisation for Netvax has been withdrawn at the request of the marketing authorisation holder.
Product information
Latest procedure affecting product information:IB/0006
19/09/2013
Product details
- Name of medicine
- Netvax
- Active substance
- Clostridium-perfringens-type-A alpha toxoid
- International non-proprietary name (INN) or common name
- adjuvanted vaccine against necrotic enteritis of chickens due to Clostridium perfringens
- Species
- Chicken
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QI01AB08
Pharmacotherapeutic group
Immunologicals for avesTherapeutic indication
For the active immunisation of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.
To reduce mortality and the incidence and severity of lesions caused by Clostridium-perfringens-type-A-induced necrotic enteritis. Efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.
The onset of passive transfer of immunity: 6 weeks following completion of the vaccination procedure.
The duration of passive transfer of immunity: 51 weeks following completion of the vaccination procedure.
News on Netvax
This page was last updated on